NOW ENROLLING

The ExoLuminate Study

A clinical study for those at risk for developing pancreatic cancer

You have the power to help change how we treat pancreatic cancer.

If you have a history of pancreatic cancer in your family, you know better than anyone that it’s among the most challenging cancers for doctors to treat – and for patients to fight.

That’s because pancreatic cancer is most often diagnosed when symptoms present in the later stages of disease, in Stage 3 or Stage 4, leaving patients and their doctors with limited options. To address this challenge, Biological Dynamics is developing a test to detect pancreatic cancer as early as Stage 1.

By joining the clinical study of our test, you’ll be playing an important role in improving the lives of those affected by pancreatic cancer and bringing hope to millions of families.

The challenge of pancreatic cancer

0K

people diagnosed with pancreatic cancer each year

0%

of patients are diagnosed in Stage 3 or 4

0K

of these patients die of it each year

0%

five-year survival rate
Source: American Cancer Society stats on pancreatic cancer in the U.S.

Who’s at risk for pancreatic cancer

There are several factors that could put you at increased risk for pancreatic cancer:

Modifiable risk factors

  • Tobacco use
  • Alcohol use (> 3 drinks daily)
  • Obesity BMI (> 40)
  • Diet high in red and processed meats

Non-modifiable risk factors

  • Race and ethnicity (higher incidence in African American and Ashkenazi Jewish populations)
  • Advancing Age (over > 50 years)
  • Cystic lesions on the pancreas
  • Diabetes Type 2 (long-standing and new-onset)
  • Pancreatitis (acute, chronic or familial)
  • Family history of pancreatic cancer
  • Personal history or strong family history of other cancer types: breast, ovarian or colon cancer or malignant melanoma
  • Inherited genetic mutations and syndrome

Genetic mutations that elevate your risk for pancreatic cancer

BRCA1
BRCA2
PALB2
CDKN2
ATM
TP53
STK11

MLH1
MSH2
MSH6
PMS2
PRSS1
EPCAM

Genetic syndromes that elevate your risk for pancreatic cancer

Cystic Fibrosis

Familial Adenomatous Polyposis (FAP)

Familial Atypical Multiple Mole Melanoma (FAMMM)

Hereditary Nonpolyposis Colorectal Cancer (HNPCC) or Lynch Syndrome

Hereditary Pancreatitis

Peutz-Jeghers Syndrome

A high-sensitivity test for a high-risk population †

The new investigational test by Biological Dynamics is powered by a patented technology that detects exosomes. Exosomes are made and released by tumor cells and contain tumor signatures. A test that can identify or measure these exosomes may be effective in early, non-invasive detection, prognosis and treatment monitoring of many types of cancer.

 

LEARN MORE ABOUT THE RESEARCH ON OUR TEST HERE:

Frontiers in Bioengineering and Biotechnology
Nature’s Communication Medicine

† Performance claims based on results of initial validation data set that demonstrated 90% sensitivity and 92.8% specificity. Results are to be submitted for peer review.

Our lab is CLIA/CAP accredited
Our lab developed test (LDT) has been listed with CMS

Do you qualify for our study?

You may be eligible to participate*
in the ExoLuminate test study if you
have a personal or family history
of pancreatic cancer and:

  • Are 18 years of age or older

  • Are able to provide a blood sample

    AND if you have at least one of the following:

  • Cystic lesions on the pancreas

  • Newly-diagnosed diabetes type 2 after age 50

  • Pancreatitis (acute, chronic or familial)

  • Family history of pancreatic cancer

  • Genetic predisposition of pancreatic cancer

*Pregnant females or those undergoing any active treatment from cancer diagnosis are not eligible to participate

Pancreatic cancer patients need you.

By joining this groundbreaking study, you have the chance to make a difference in the lives of patients with pancreatic cancer, as well as the families who love them.

To participate, all you’ll need to do is get your blood drawn – at no cost to you – up to three times, either at your neighborhood lab or at your home with our mobile health team.

Just ask your doctor about enrolling in the ExoLuminate study or fill out our form and one of our specialists will be in touch.

    First Name*
    Last Name*
    Email Address*
    Phone Number
    Are you a:*
    City
    State
    Zip
    How did you hear about ExoLuminate*?
    Please enter how you heard about ExoLuminate
    Message

    Contact Us

    Email
    Phone
    858-202-6150
    Let’s get social
    For detailed study information
    ClinicalTrials.Gov

    About Biological Dynamics

    Biological Dynamics, Inc. is a biotechnology company committed to improving global health outcomes by detecting diseases in the earliest stages. Our proprietary platform simplifies access to extracellular vesicles enabling multiomic analysis. Our test may have many applications in early disease detection, going beyond cancer to other health issues such as kidney and infectious diseases.

    For more information: https://exoluminate.com